Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by University of Tennessee Cancer Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
National Comprehensive Cancer Network
Celgene Corporation
Genentech, Inc.
Information provided by (Responsible Party):
University of Tennessee Cancer Institute
ClinicalTrials.gov Identifier:
NCT00777673
First received: October 20, 2008
Last updated: January 3, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)